Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
LI

LIVN

Market Closed

LivaNova PLC

NASDAQHealthcareMedical - Devices
GB
3.30K employees
CEO: Vladimir A. Makatsaria
Founded: 2015
$81.36
+$0.00(+NaN%)
Market Cap
4.47B
Beta
0.87
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Based on PERT weighted analysis (confidence: high), the fair value is $40.72, implying 49.3% downside from current levels. The stock appears significantly overvalued. Financial health scores indicate moderate fundamentals (2.0/5). Monte Carlo analysis shows low downside risk (0% of scenarios below current price). Overall, this suggests a elevated valuation risk at current prices.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore LIVN

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

LIVN in the Healthcare

Mid Cap
Healthcare

Browse sector stocks →

Medical - Devices

Browse industry stocks →